4.7 Review

Therapeutics in Cancer - An Emerging Concept

期刊

EBIOMEDICINE
卷 12, 期 -, 页码 34-42

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2016.09.017

关键词

microRNA; Non-coding RNA; Cancer; Therapeutics; Clinical trials

资金

  1. NIH/NCI [1UH2TR00943-01, 1 R01 CA182905-01]
  2. UT MD Anderson Cancer Center SPORE in Melanoma grant from NCI [P50 CA093459]
  3. Aim at Melanoma Foundation
  4. Miriam and Jim Mulva research funds
  5. UT MD Anderson Cancer Center Brain SPORE [2P50CA127001]
  6. Leukemia SPORE
  7. CLL Moonshot Flagship project
  8. Knowledge GAP MDACC grant
  9. Owens Foundation
  10. RGK Foundation

向作者/读者索取更多资源

MicroRNAs (miRNAs) are an evolutionarily conserved class of small, regulatory non-coding RNAs that negatively regulate protein coding gene and other non-coding transcripts expression. miRNAs have been established as master regulators of cellular processes, and they play a vital role in tumor initiation, progression and metastasis. Further, widespread deregulation of microRNAs have been reported in several cancers, with several microRNAs playing oncogenic and tumor suppressive roles. Based on these, miRNAs have emerged as promising therapeutic tools for cancer management. In this review, we have focused on the roles of miRNAs in tumorigenesis, the miRNA-based therapeutic strategies currently being evaluated for use in cancer, and the advantages and current challenges to their use in the clinic. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据